Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Julio RosenstockMichael R Jones

Abstract

To evaluate the efficacy and safety of initial combination therapy with metformin plus colesevelam in patients with early type 2 diabetes. In this 16-week, randomized, double-blind, placebo-controlled study, adults with type 2 diabetes (hemoglobin A1c [A1C] values of 6.5% to 10.0%) and hypercholesterolemia (low-density lipoprotein cholesterol [LDL-C] levels > or =100 mg/dL) were randomly assigned (1:1) to colesevelam (3.75 g/d) or placebo in combination with open-label metformin (850 mg/d; uptitrated at week 2 to 1,700 mg/d). The primary efficacy evaluation was change in A1C from baseline to study end (week 16 with last observation carried forward). In total, 286 patients were randomized: metformin/colesevelam (n = 145) or metformin/placebo (n = 141). Mean A1C was reduced by 1.1% with metformin/colesevelam (from 7.8% at baseline to 6.6% at study end) and by 0.8% with metformin/placebo (from 7.5% to 6.7%), resulting in a treatment difference of -0.3% at study end (P = .0035). In addition, metformin/colesevelam significantly reduced LDL-C (-16.3%), total cholesterol (-6.1%), non-high-density lipoprotein cholesterol (-8.3%), apolipoprotein B (-8.0%), and high-sensitivity C-reactive protein (-17%) and increased apolipoprotein A-I (...Continue Reading

References

Sep 1, 1983·Diabetes Care·P DandonaA G Beckett
Feb 20, 2007·The American Journal of Cardiology·Michael H Davidson
Dec 22, 2007·Expert Review of Cardiovascular Therapy·Prakash Deedwania, Sundararajan Srikanth
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Oct 28, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardStanley S Schwartz
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jul 31, 2013·Cardiovascular Drugs and Therapy·Robert S Rosenson, James A Underberg
Jul 9, 2011·Internal and Emergency Medicine·Franco ScaldaferriAntonio Gasbarrini
Oct 16, 2010·Metabolic Syndrome and Related Disorders·Philip Levy
Jul 19, 2012·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Harold E Bays
Apr 30, 2014·Drugs & Aging·James R GavinKenneth E Truitt
Apr 9, 2014·Cardiovascular Drugs and Therapy·Robert S RosensonHubert S Chou
May 14, 2014·Nature Reviews. Endocrinology·Folkert KuipersAlbert K Groen
Aug 21, 2014·Biochimica Et Biophysica Acta·Raffaella Maria GadaletaAntonio Moschetta
Mar 22, 2012·Expert Opinion on Drug Metabolism & Toxicology·Lisa M Younk, Stephen N Davis
Jan 20, 2011·Expert Opinion on Drug Safety·Nicholas AvitabileVivian A Fonseca
Sep 13, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·C P Ooi, S C Loke
Aug 5, 2011·The American Journal of Cardiology·Gloria Lena VegaScott M Grundy
Nov 21, 2015·Canadian Journal of Diabetes·Supna SandhuGordon A Francis
May 6, 2011·Diabetes Care·Yehuda Handelsman
Aug 5, 2011·Journal of Pharmacy Practice·Luigi Brunetti, R Keith Campbell
Dec 19, 2013·Clinical Medicine Insights. Endocrinology and Diabetes·Oliseyenum M Nwose, Michael R Jones
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Cheow Peng Ooi, Seng Cheong Loke
Jun 6, 2015·Circulation. Cardiovascular Genetics·Stephanie RossGuillaume Paré
Dec 7, 2011·Expert Review of Clinical Pharmacology·Yehuda HandelsmanJulio Rosenstock
Aug 30, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Xiaoling CaiLinong Ji
Nov 16, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Ronald B GoldbergMichael R Jones
Feb 6, 2017·Drugs·Cristina BianchiStefano Del Prato
Nov 19, 2020·The Journal of Pharmacology and Experimental Therapeutics·Tamara R CastañedaThomas Hübschle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.